Highlights of ACC 2024
Cardiology Update
APRIL 9, 2024
The primary superiority endpoint was clinically relevant bleeding (Bleeding Academic Research Consortium [known as BARC] types 2, 3, or 5). These patients were identified to have non-flow-limiting vulnerable coronary plaques through intracoronary imaging.
Let's personalize your content